Tekturna and Bradycardia - a phase IV clinical study of FDA data

Summary:

Bradycardia is reported as a side effect among people who take Tekturna (aliskiren hemifumarate), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Aspirin, and have Cardiac failure congestive.

The phase IV clinical study analyzes which people have Bradycardia when taking Tekturna. It is created by eHealthMe based on reports of 4,498 people who have side effects when taking Tekturna from the FDA, and is updated regularly.

What is Tekturna?

Tekturna has active ingredients of aliskiren hemifumarate. It is often used in high blood pressure. eHealthMe is studying from 4,730 Tekturna users. Check the latest studies of Tekturna.

What is Bradycardia?

Bradycardia (abnormally slow heart action) is found to be associated with 1,924 drugs and 3,119 conditions by eHealthMe. Check the latest studies of Bradycardia.

On May, 05, 2026

4,498 people reported to have side effects when taking Tekturna.
Among them, 20 people (0.44%) have Bradycardia.

Among these 20 people:

How long have people been on Tekturna when they have Bradycardia? *

What is the gender of people who have Bradycardia when taking Tekturna? *

female: 50 %
male: 50 %

What is the age of people who have Bradycardia when taking Tekturna? *

What are other drugs people take besides Tekturna? *

What are other side effects people have besides Bradycardia? *

Dyspnea (difficult or laboured breathing): 11 people, 55.00%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 9 people, 45.00%
Hyperkalemia (damage to or disease of the kidney): 8 people, 40.00%
Blood Creatinine Increased: 7 people, 35.00%
Hypotension (abnormally low blood pressure): 6 people, 30.00%
Visual Impairment: 5 people, 25.00%
Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 25.00%
Dizziness: 5 people, 25.00%
Pain: 5 people, 25.00%
Blood Urea Increased: 5 people, 25.00%

What are the existing conditions these people have? *

Cardiac Failure Congestive: 4 people, 20.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
Oedema (fluid collection in tissue): 2 people, 10.00%
Multiple Allergies (allergy to multiple agents): 2 people, 10.00%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 5.00%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 5.00%
Arthropathy: 1 person, 5.00%
Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 5.00%
Bipolar Disorder (mood disorder): 1 person, 5.00%
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 1 person, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Tekturna and have Bradycardia?

- Check whether Bradycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tekturna:

Tekturna (4,730 reports)

Bradycardia treatments and more:

Bradycardia (61,180 reports)

Browse all side effects of Tekturna:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Bradycardia:

Bradycardia (1,924 drugs)

Browse all the conditions that are associated with Bradycardia:

Bradycardia (3,119 conditions)

Related publications that referenced our studies

Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .
Schlumbrecht MP, Hehr K, "Cisplatin-induced bradycardia and the importance of the QT interval", Journal of Oncology Pharmacy Practice, 2015 Jan .
Oflaz MB, Kucukdurmaz Z, Guven AS, Karapinar H, Kaya A, Sancakdar E, Deveci K, Gul I, Erdem A, Cevit O, Icagasioglu FD, "Bradycardia seen in children with Crimean-Congo hemorrhagic fever", Vector-Borne and Zoonotic Diseases, 2013 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on aliskiren hemifumarate (the active ingredients of Tekturna) and Tekturna (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.